Skip to content

A Trial to compare two drugs used to prevent complications of post operative nausea and vomiting after neurosurgery

COMPARISON OF INTRAVENOUS ONDANSETRON VERSUS COMBINATION OF INTRAVENOUS ONDANSETRON AND ORAL APPREPITANT TO PREVENT POST OPERATIVE NAUSEA VOMITING IN PATIENTS UNDERGOING ELECTIVE CRANIOTOMIES A PROSPECTIVE RANDOMISED CONTROL TRIAL. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083055
Enrollment
128
Registered
2025-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Administration of study drug/drugs: Patients who meet the criteria for the study will be divided into two groups using a computer generated random table and administered the study drug/

Sponsors

DrVanchula Srinivasan
Lead Sponsor
DrPonniah Vanamoorthy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Consenting patients undergoing Elective Craniotomy surgeries, under ASA grades 1 and 2.

Exclusion criteria

Exclusion criteria: Non consenting patients Pregnant patients ASA grading 3 and above Patients with known or suspected to have allergy for study drug Emergency surgery

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of IV ondansetron when given alone versus combination of IV ondansetron and Oral aprepitant in management of PONV in patients undergoing elective craniotomy surgeries.Timepoint: Incidence of PONV will be recorded at initial 0 to 2 hours, at 2 to 6 hours, 6 to 24 and 24 to 48 hours postoperatively.

Secondary

MeasureTime frame
Assess the incidence of PONV in patients undergoing elective craniotomy surgeries. To assess timing and need for rescue anti-emetic and/ or repeat dosing of same drug in treating PONV.Timepoint: Incidence of PONV will be recorded at initial 0 to 2 hours, at 2 to 6 hours, 6 to 24 and 24 to 48 hours postoperatively.

Countries

India

Contacts

Public ContactDrVanchula Srinivasan

Kauvery Institute of Brain and Spine, Kauvery Hospital,Radial Road

drvanchula@gmail.com9940672171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026